OOIR: Observatory of International Research

Papers

(The H4-Index of Drugs is 58. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Correction: Targeting KRASG12C in Non-Small-Cell Lung Cancer: Current Standards and Developments	471
Correction: New Pharmacologic Approaches to the Treatment of Bipolar Depression	407
Suprachoroidal Space Triamcinolone Acetonide: A Review in Uveitic Macular Edema	245
Targeting DNA Damage Response Deficiency in Thoracic Cancers	216
New Therapies on the Horizon for Primary Biliary Cholangitis	213
Clinical Efficacy, Safety and Imaging Effects of Oral Valiltramiprosate in APOEε4/ε4 Homozygotes with Early Alzheimer’s Disease: Results of the Phase III, Randomized, Double-Blind, Placebo-Controlled,	197
Eftrenonacog Alfa: A Review in Haemophilia B	189
Comment on “Recent Human Papillomavirus Vaccination is Associated with a Lower Risk of COVID-19: A US Database Cohort Study”	162
Aztreonam-Avibactam: A Review in the Treatment of Serious Bacterial Infections Caused by Aerobic Gram-Negative Organisms	151
Authors’ Reply to Toda: Multimodal Multidisciplinary Management of Patients with Moderate to Severe Pain in Knee Osteoarthritis: A Need to Meet Patient Expectations	149
Acknowledgement to Referees	142
Alcohol-Associated Liver Disease: Evolving Concepts and Treatments	132
Asthma and Cardiovascular Diseases: Navigating Mutual Pharmacological Interferences	129
Aprocitentan: First Approval	129
Vorasidenib: First Approval	127
Senaparib: First Approval	120
Analysis of Cerebrospinal Fluid, Plasma β-Amyloid Biomarkers, and Cognition from a 2-Year Phase 2 Trial Evaluating Oral ALZ-801/Valiltramiprosate in APOE4 Carriers with Early Alzheimer’s Disease Using	117
Teclistamab: First Approval	112
Spesolimab for the Treatment of Generalized Pustular Psoriasis	111
Efficacy and Safety of Plecanatide in Chinese Patients with Functional Constipation: A Phase III Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial	108
Epcoritamab: First Approval	108
Ivarmacitinib Sulfate: First Approval	105
Olipudase Alfa: First Approval	102
Cosibelimab: First Approval	102
Advances in Pharmacotherapy for Menopausal Vasomotor Symptoms	96

Tolebrutinib: First Approval	92
Drugs in Development to Manage Acute Pain	91
QT Prolongation and Risk of Death with the Use of Methadone for Chronic Cancer and Noncancer Pain: Myths or Reality?	88
Lenacapavir: First Approval	88
Danicopan: First Approval	88
Efficacy and Safety of CDK4/6 Inhibitors: A Focus on HR+/HER2− Early Breast Cancer	86
Safety of Anti-osteoarthritis Medications: A Systematic Literature Review of Post-marketing Surveillance Studies	85
Repotrectinib: First Approval	85
Influenza Vaccine Effectiveness and Progress Towards a Universal Influenza Vaccine	84
Acoltremon: First Approval	84
Emerging Therapies for Chronic Hepatitis B and the Potential for a Functional Cure	83
Delgocitinib 20 mg/g Cream: A Review in Chronic Hand Eczema	80
Androgenetic Alopecia: Therapy Update	80
Alzheimer’s Disease: Novel Targets and Investigational Drugs for Disease Modification	78
SER-109 (VOWST™): A Review in the Prevention of Recurrent Clostridioides difficile Infection	73
Treatment of Cryptococcal Meningitis: How Have We Got Here and Where are We Going?	73
Mazdutide: First Approval	72
Cancer Pain Treatment Strategies in Patients with Cancer	70
Novel Drugs for the Treatment of Pulmonary Arterial Hypertension: Where Are We Going?	69
Mosunetuzumab: First Approval	69
Olverembatinib: First Approval	68
Relugolix/Estradiol/Norethisterone (Norethindrone) Acetate: A Review in Symptomatic Uterine Fibroids	67
Managing Burning Mouth Syndrome: Current and Future Directions	67
Correction to: Tapinarof Cream 1%: First Approval	65
Situational Prevention of Migraine Attacks: Can Early Treatment Change the Conversation?	65
Drugs Targeting Cough Receptors: New Therapeutic Options in Refractory or Unexplained Chronic Cough	64
Correction to: Fenfluramine: A Review in Dravet and Lennox-Gastaut Syndromes	64
Correction to: Prevention and Treatment of Monkeypox	61
Taletrectinib: First Approval	60
Sunvozertinib: First Approval	59
The Place of Cannabinoids in the Treatment of Gynecological Pain	59
Dorzagliatin: First Approval	58
Pozelimab: First Approval	58